Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients

(2016) F. El Chaer et al.   BLOOD

Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood

(2015) C Solano et al.   BONE MARROW TRANSPLANTATION

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality

(2015) J. Liu et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center

(2013) C Solano et al.   BONE MARROW TRANSPLANTATION

Management of cytomegalovirus infection in haemopoietic stem cell transplantation

(2013) Vincent Emery et al.   BRITISH JOURNAL OF HAEMATOLOGY

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

(2013) Einat Shmueli et al.   JOURNAL OF INFECTIOUS DISEASES

Recombinant Phenotyping of Cytomegalovirus UL54 Mutations That Emerged during Cell Passages in the Presence of either Ganciclovir or Foscarnet

(2011) Christian Gilbert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients

(2011) Martha T van der Beek et al.   ANTIVIRAL THERAPY

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

(2010) S. Hantz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

(2009) N Tormo et al.   BONE MARROW TRANSPLANTATION